Ads
related to: should you take pepto bismol for stomach flu
Search results
Results From The WOW.Com Content Network
Bismuth subsalicylate, sold generically as pink bismuth and under brand names including Pepto-Bismol, Pepti-Calm and BisBacter, is a medication used to treat temporary discomfort of the stomach and gastrointestinal tract. This includes an upset stomach, heartburn or other similar symptoms.
You took bismuth medications. Bismuth medications are usually used to treat diarrhea, upset stomach, and heartburn, and can include brands like Pepto-Bismol and Kaopectate. But while they can calm ...
Antimotility agents are drugs used to alleviate the symptoms of diarrhea. These include loperamide (Imodium), bismuth subsalicylate (Pepto-Bismol), [1] diphenoxylate with atropine (Lomotil), and opiates such as paregoric, tincture of opium, codeine, and morphine.
How long does it take to rehydrate after stomach flu? Full recovery from dehydration may take a few days, depending on how much fluid was lost. Most people will show improvement within a few hours ...
The 24-hour flu is usually a type of gastroenteritis, which is an inflammation of the intestines and stomach, says William Schaffner, M.D., an infectious disease specialist and professor at the ...
Just how does Pepto treat all those GI discomforts? --24.249.108.133 23:05, 31 May 2007 (UTC) The Pepto forms a coat in the stomach, getting between the stomach contents and the stomach lining. In the process, pepto allows the digestive tract to fuction as it otherwise would, clearing up the digestive problems for the person using it.
According to CDC figures, more than 200 outbreaks of norovirus — which is sometimes referred to as the stomach flu or stomach bug, though it has no official ties to influenza — have occurred ...
The active ingredient in Kaopectate has changed since its original creation. Originally, kaolinite was used as the adsorbent and pectin as the emollient. Attapulgite (a type of absorbent clay) replaced the kaolinite in the 1980s, but was banned by the U.S. Food and Drug Administration in a ruling made in April 2003.